sickle cell - Nursing Case Study
Pathophysiology
• Primary mechanism: Sickle cell disease is caused by a genetic mutation in the HBB gene, leading to the production of abnormal hemoglobin S (HbS). This mutated hemoglobin polymerizes under low oxygen conditions, causing red blood cells to become rigid, deformed, and sickle-shaped.
• Secondary mechanism: The sickle-shaped cells have a reduced lifespan and are prone to hemolysis. They also obstruct microcirculation by adhering to the vascular endothelium, causing vaso-occlusive crises and ischemic tissue damage.
• Key complication: Repeated vaso-occlusion and hemolysis contribute to chronic anemia, pain crises, and organ damage, particularly affecting the spleen, kidneys, and lungs, leading to increased risk of infections and acute chest syndrome.
Patient Profile
Demographics:
28-year-old female, teacher
History:
• Key past medical history: Sickle cell disease diagnosed at age 5, history of vaso-occlusive crises occurring 2-3 times per year, mild asthma
• Current medications: Hydroxyurea, folic acid, ibuprofen as needed for pain, albuterol inhaler
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing episodes of fatigue and shortness of breath over the past month
• Key symptoms: Pain in joints and abdomen, mild jaundice, palpitations, occasional dizziness
• Vital signs: Temperature 100.4°F, heart rate 112 bpm, blood pressure 100/60 mmHg, respiratory rate 22 breaths per minute, oxygen saturation 92% on room air
Section 1
Initial Assessment Findings:
Upon further assessment in the emergency department, the patient exhibits pallor and mild scleral icterus, indicating ongoing hemolysis and possible anemia. Her lung auscultation reveals decreased breath sounds at the bases and mild crackles, suggesting potential pulmonary complications. The patient's abdominal examination indicates tenderness in the right upper quadrant, which could be indicative of hepatomegaly or gallbladder involvement due to chronic hemolysis. Her joint examination reveals warmth and tenderness in the knees and elbows, consistent with vaso-occlusive pain.
The laboratory results are telling: Hemoglobin is significantly decreased at 7.2 g/dL, showing worsening anemia. Reticulocyte count is elevated at 7%, reflecting a compensatory bone marrow response. Total bilirubin is elevated at 4.5 mg/dL, primarily indirect, correlating with increased hemolysis. Her lactate dehydrogenase (LDH) is elevated, further confirming hemolytic activity. A chest X-ray is performed, revealing bilateral infiltrates suggestive of early acute chest syndrome, a serious complication in sickle cell disease.
The clinical team is particularly concerned about the respiratory status due to the low oxygen saturation and the potential development of acute chest syndrome. They initiate supplemental oxygen therapy and plan for a possible exchange transfusion if her respiratory status deteriorates. The patient's pain management is optimized with intravenous fluids and analgesics to address the ongoing vaso-occlusive crisis. This comprehensive approach will help stabilize her current condition, but vigilant monitoring is crucial given the risk of further complications.
Section 2
As the clinical team continues to monitor the patient, they note a change in her respiratory status. Despite supplemental oxygen therapy, her oxygen saturation has decreased to 89% on room air, prompting an increase in oxygen delivery. The patient begins to exhibit increased work of breathing, with nasal flaring and use of accessory muscles. Her respiratory rate has climbed to 28 breaths per minute, and she is visibly anxious, expressing difficulty in catching her breath. Auscultation of the lungs now reveals more pronounced crackles, particularly in the lower lobes, and the patient reports a sharp, pleuritic pain on inspiration.
In light of these developments, the team orders an arterial blood gas (ABG) analysis, which shows a pH of 7.31, PaCO2 of 50 mmHg, PaO2 of 58 mmHg, and HCO3- of 24 mEq/L, indicating acute respiratory acidosis with hypoxemia. This confirms the suspicion of worsening acute chest syndrome, a life-threatening complication that necessitates immediate intervention. The decision is made to proceed with an urgent exchange transfusion to rapidly reduce the sickled erythrocyte load and improve oxygenation.
Throughout this process, the team maintains a multidisciplinary approach, involving respiratory therapy for potential non-invasive ventilation support, and hematology for the transfusion protocol. As the patient is prepared for the exchange transfusion, her vital signs are closely monitored, with particular attention to her heart rate, which has increased to 112 beats per minute, and her blood pressure, which remains stable at 110/70 mmHg. The intervention aims to alleviate the acute respiratory distress and stabilize her condition, but the team is aware of the need for ongoing vigilance for any further complications, such as potential infections or multi-organ involvement.
Section 3
As the exchange transfusion proceeds, the clinical team closely monitors the patient's response to the intervention. Initially, there are promising signs of improvement; her oxygen saturation begins to rise to 94% with the supplemental oxygen, and her respiratory rate decreases to 22 breaths per minute. The patient reports a slight reduction in pleuritic pain, and her anxiety appears to be diminishing. However, as the procedure continues, a new complication arises.
The patient starts to show signs of acute kidney injury, evidenced by a sudden decrease in urine output to less than 0.5 mL/kg/hr. Blood tests reveal an elevated serum creatinine level of 2.1 mg/dL, up from a baseline of 0.9 mg/dL. Her blood urea nitrogen (BUN) is also elevated at 28 mg/dL. The nephrology team is consulted to assess the need for renal support and determine whether the kidney impairment is a result of sickle cell-related vaso-occlusive events or secondary to the transfusion. The team orders a renal ultrasound to rule out any obstructive causes and considers the possibility of initiating fluid management strategies to support renal function.
This new development prompts the clinical team to revisit the patient's overall treatment plan, emphasizing the need for a balance between aggressive management of acute chest syndrome and careful monitoring of renal function. The need for a multidisciplinary approach becomes even more critical, as the team must now integrate nephrology insights into the patient's care. The focus shifts to preventing further renal compromise while continuing to address her respiratory distress, highlighting the complexity and interconnected nature of managing sickle cell complications. This situation underscores the importance of vigilant monitoring and timely decision-making in a dynamic clinical scenario.
Section 4
As the clinical team continues to monitor the patient, a change in her status becomes evident. Despite initial improvements following the exchange transfusion, her respiratory status begins to deteriorate again. Her oxygen saturation drops slightly to 91% even with supplemental oxygen, and her respiratory rate increases to 28 breaths per minute. The patient expresses discomfort, describing a sensation of increased chest tightness and a resurgence of pleuritic pain. Auscultation of her lungs reveals diminished breath sounds at the bases, and there is a noted increase in inspiratory crackles, suggesting possible fluid overload or pulmonary edema.
In response to these developments, the team conducts an arterial blood gas analysis which reveals a pH of 7.32, indicating a mild respiratory acidosis. Her PaO2 is 62 mmHg, further confirming her respiratory compromise. Meanwhile, her renal function continues to show signs of stress, with urine output remaining low at 0.3 mL/kg/hr. The nephrology team recommends cautious fluid management to avoid exacerbating pulmonary issues while attempting to protect renal function. They suggest administering a diuretic to address potential fluid overload, but with careful titration to prevent further reduction in renal perfusion.
The clinical team faces a challenging balance between managing the acute chest syndrome and preventing further renal and respiratory deterioration. The patient's condition necessitates a thorough reassessment of her treatment plan, underscoring the need for close collaboration between pulmonology, nephrology, and critical care specialists. The priority is to stabilize her respiratory status while minimizing renal impairment, demonstrating the intricate interplay of clinical reasoning required in managing complex sickle cell complications. The next steps include adjusting her fluid and respiratory therapy while preparing for potential further interventions, such as non-invasive ventilation or dialysis, should her condition warrant it.
Section 5
Despite the team's careful management, the patient's condition continues to evolve, presenting new challenges. Over the next few hours, her respiratory status stabilizes slightly with a decrease in her respiratory rate to 24 breaths per minute, but her oxygen saturation remains borderline at 92% with 6L of supplemental oxygen via nasal cannula. The pulmonology team decides to initiate non-invasive positive pressure ventilation (NIPPV) to improve her oxygenation and reduce the work of breathing. This intervention shows some promise, as her oxygen saturation improves to 95%, though she still reports mild chest discomfort. Her vital signs show a heart rate of 112 beats per minute and a blood pressure of 128/78 mmHg.
Meanwhile, new diagnostic results arrive, highlighting an important shift in her clinical picture. A repeat chest X-ray indicates bilateral infiltrates, confirming the suspicion of acute chest syndrome exacerbated by possible fluid overload. A Doppler ultrasound of her kidneys reveals reduced perfusion, contributing to her ongoing oliguria. Her laboratory results show a serum creatinine level that has risen to 2.1 mg/dL, indicating worsening renal function. In light of these findings, the nephrology team advocates for continued cautious diuretic therapy while closely monitoring her electrolyte balance and renal parameters.
The team recognizes the delicate balance required in addressing the intertwined complications of acute chest syndrome and renal impairment. They adjust her fluid management plan, opting for a slow, judicious administration of intravenous diuretics while ensuring adequate hydration to support renal function. The patient's care plan is revised to include regular reassessments of her respiratory and renal status, with the possibility of renal replacement therapy if her renal function deteriorates further. The interdisciplinary team's collaborative approach is crucial in navigating this complex clinical scenario, underscoring the importance of dynamic clinical reasoning in managing sickle cell complications.